Navigation Links
MIT Changes Its Name to Micro Identification Technologies
Date:2/19/2010

SAN CLEMENTE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Micro Imaging Technology, Inc. (OTC: Bulletin Board: MMTC) today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software. The company currently produces the MIT 1000 Rapid Microbial Identification (ID) System that can identify bacteria in less than five minutes with a laser that uses the principles of light scattering and with proprietary PC-based software algorithms to test bacteria samples at less than $.10 per test.

"Our company's mission is to become an advanced identifier for a variety of applications spanning several industries and we felt our name should reflect this objective," stated Michael Brennan, MIT's Chairman and CEO.

MIT's primary focus is in food safety where over the past few years a vast amount of food contamination events have been recorded. The Center for Disease Control reports that over 325,000 food contamination events causing 5,000 deaths annually.  

MIT's technology can also be used for applications in clinical diagnostics, pharmaceutical and semiconductor processing as well as drinking water testing. Each of these applications will be pursued over the next few years. The technology is also adaptable to perform identification in air.

About Micro Identification Technologies

Micro Identification Technologies is a California-based public company that has developed and patented a rapid microbial identification (ID) System that revolutionizes the pathogenic bacteria ID process and can annually save thousands of lives and tens of millions of dollars. The system can identify bacteria in minutes at significant savings. It does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis.  Revenues for all rapid testing methods exceed $5 billion annually – with food safety accounting for over $3 billion - having expanded at a rate of 9.2 percent annually since 1998. Current growth projections are at 30% annually with test demands driven by major health, safety and homeland security issues. For more information, please visit www.micro-identification.com

This release contains statements that are forward-looking in nature.  Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements.  These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements.  These statements are not guarantees of future performance and actual results could differ materially from our current expectations.  Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

SOURCE Micro Identification Technologies

Back to top

RELATED LINKS
http://www.micro-identification.com

'/>"/>

SOURCE Micro Identification Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Micromet Announces Changes in Management Team
3. Cancer Cure Coalition Proposes Major Changes at the FDA
4. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
5. Silence Therapeutics Announces Board Changes
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
8. Exercise Helps Prevent Age-Related Brain Changes in Older Adults
9. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
10. Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
11. Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):